These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 28544374)

  • 21. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer.
    Müller V; Oliveira-Ferrer L; Steinbach B; Pantel K; Schwarzenbach H
    Mol Oncol; 2019 May; 13(5):1137-1149. PubMed ID: 30803129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
    Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
    Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA H19 competitively binds miR-93-5p to regulate STAT3 expression in breast cancer.
    Li JP; Xiang Y; Fan LJ; Yao A; Li H; Liao XH
    J Cell Biochem; 2019 Mar; 120(3):3137-3148. PubMed ID: 30256448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
    Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
    Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b.
    Zhou W; Ye XL; Xu J; Cao MG; Fang ZY; Li LY; Guan GH; Liu Q; Qian YH; Xie D
    Sci Signal; 2017 Jun; 10(483):. PubMed ID: 28611183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of lncRNA-ATB inhibits epithelial-mesenchymal transition of breast cancer cells by increasing miR-141-3p expression.
    Zhang Y; Li J; Jia S; Wang Y; Kang Y; Zhang W
    Biochem Cell Biol; 2019 Apr; 97(2):193-200. PubMed ID: 30352165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
    Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H19 promotes non-small-cell lung cancer (NSCLC) development through STAT3 signaling via sponging miR-17.
    Huang Z; Lei W; Hu HB; Zhang H; Zhu Y
    J Cell Physiol; 2018 Oct; 233(10):6768-6776. PubMed ID: 29693721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H19 promotes the migration and invasion of colon cancer by sponging miR-138 to upregulate the expression of HMGA1.
    Yang Q; Wang X; Tang C; Chen X; He J
    Int J Oncol; 2017 May; 50(5):1801-1809. PubMed ID: 28358427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNMT1 controls LncRNA H19/ERK signal pathway in hepatic stellate cell activation and fibrosis.
    Yang JJ; She Q; Yang Y; Tao H; Li J
    Toxicol Lett; 2018 Oct; 295():325-334. PubMed ID: 30010033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer.
    Zhang W; Shi S; Jiang J; Li X; Lu H; Ren F
    Biomed Pharmacother; 2017 Jul; 91():312-319. PubMed ID: 28463794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development.
    Jin C; Yan B; Lu Q; Lin Y; Ma L
    Tumour Biol; 2016 Jun; 37(6):7383-94. PubMed ID: 26676637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H19 lncRNA mediates 17β-estradiol-induced cell proliferation in MCF-7 breast cancer cells.
    Sun H; Wang G; Peng Y; Zeng Y; Zhu QN; Li TL; Cai JQ; Zhou HH; Zhu YS
    Oncol Rep; 2015 Jun; 33(6):3045-52. PubMed ID: 25846769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA DLX6-AS1 accelerates the glioma carcinogenesis by competing endogenous sponging miR-197-5p to relieve E2F1.
    Li X; Zhang H; Wu X
    Gene; 2019 Feb; 686():1-7. PubMed ID: 30366080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway.
    Sun X; Huang T; Liu Z; Sun M; Luo S
    Eur J Pharmacol; 2019 Aug; 856():172407. PubMed ID: 31132353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lncRNA H19 Promotes Cell Proliferation by Competitively Binding to miR-200a and Derepressing
    Yang W; Ning N; Jin X
    Biomed Res Int; 2017; 2017():2767484. PubMed ID: 28164117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LINC00461 promotes cell migration and invasion in breast cancer through miR-30a-5p/integrin β3 axis.
    Dong L; Qian J; Chen F; Fan Y; Long J
    J Cell Biochem; 2019 Apr; 120(4):4851-4862. PubMed ID: 30623482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lncRNA H19 interacts with miR-140 to modulate glioma growth by targeting iASPP.
    Zhao H; Peng R; Liu Q; Liu D; Du P; Yuan J; Peng G; Liao Y
    Arch Biochem Biophys; 2016 Nov; 610():1-7. PubMed ID: 27693036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA H19 confers resistance to gefitinib via miR-148b-3p/DDAH1 axis in lung adenocarcinoma.
    Huang Z; Ma Y; Zhang P; Si J; Xiong Y; Yang Y
    Anticancer Drugs; 2020 Jan; 31(1):44-54. PubMed ID: 31503013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.